Brian Chang is CTO of X-COR Therapeutics, a medical device company that is developing novel extracorporeal CO2 removal (ECCO2R) devices to treat acute respiratory failure.
More About Brian
Prior to X-COR, Brian received his PhD in medical engineering from MIT. He completed his thesis under the supervision of Elazer Edelman and is an expert in cardiopulmonary support technology.
Brian has an PhD from MIT and a BS/MS in Mechanical Engineering from Carnegie Mellon University.